CFO departure
PDS Biotechnology Corporation discloses CFO departure: Lars Boesgaard
PDS Biotechnology Corporation reported in a Form 8-K filed August 19, 2026 a change involving its Chief Financial Officer, Lars Boesgaard, effective September 12, 2026. The filing's own words are quoted below.
In the filing's words
On August 13, 2026, Lars Boesgaard submitted his resignation, effective as of September 12, 2026, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the “ Company ”) in order to pursue other professional endeavors.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | PDS Biotechnology Corporation (PDSB) |
|---|---|
| Event | Departure |
| Outgoing | Lars Boesgaard |
| Effective | September 12, 2026 |
| 8-K filed | August 19, 2026 |
| SEC CIK | 0001472091 |
PDS Biotechnology Corporation reported this change in a Form 8-K, Item 5.02, filed August 19, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Lars Boesgaard? Send a correction with the primary source.